Non-malignant drivers of elevated C-reactive protein levels differ in patients with and without a history of cancer

Molecular Diagnosis and Therapy

Volumn 14, Issue 5, 2010, Pages 295-303

  Johnson, Timothy V ^a   Master, Viraj A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC VALUE; ETHNICITY; FEMALE; HIGH RISK PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; METASTASIS; MORTALITY; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING; SOCIAL ASPECT; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS;

EID: 78149399860     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.2165/11539670-000000000-00000     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49
2. Canna K, McMillan DC, McKee RF, et al. Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. Br J Cancer 2004; 90: 1707-9
3. JabsWJ, Busse M, Kruger S, et al. Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. Kidney Int 2005; 68: 2103-10
4. McKeown DJ, Brown DJ, Kelly A, et al. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer. Br J Cancer 2004; 91: 1993-5
5. Gagnon B, Abrahamowicz M, Xiao Y, et al. Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer. Br J Cancer 2010; 102: 1113-22
6. Hefler-Frischmuth K, Seebacher V, Polterauer S, et al. The inflammationbased modified Glasgow Prognostic Score in patients with vulvar cancer. Eur J Obstet Gynecol Reprod Biol 2010; 149: 102-5
7. Johnson TV, Abbasi A, Owen-Smith A, et al. Absolute preoperative C-reactive protein predicts metastasis andmortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma. J Urol 2010; 183: 480-5
8. Johnson TV, Abbasi A, Owen-Smith A, et al. Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology 2010 Sep; 76 (3): 766.e1-5
9. Ljungberg B. Prognostic markers in renal cell carcinoma. Curr OpinUrol 2007; 17: 303-8
10. Iimura Y, Saito K, Fujii Y, et al. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein andTNMclassification: the TNM-C score. J Urol 2009Mar; 181 (3): 1004-12; discussion 1012
11. Karakiewicz PI, Hutterer GC, Trinh QD, et al. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer 2007; 110: 1241-7
12. Ramsey S, Lamb GW, Aitchison M, et al. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer. BJU Int 2008; 101: 959-63
13. Johnson TV, Young AN, Osunkoya AO, et al. C-reactive protein as a clinically useful biomarker of metastasis of renal cell carcinoma.Mol Diagn Ther 2010; 14 (3): 191-3
14. Tatokoro M, Saito K, Iimura Y, et al. Prognostic impact of postoperative C-reactive protein level in patientswith metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. J Urol 2008; 180: 515-9
15. Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun 2007; 21: 901-12
16. Johnson T, Abbasi A, Ehrlich S, et al. Nocturia associated with depressive symptoms. Urology. Epub 2010 Jul 2
17. Johnson T, Abbasi A, Ehrlich S, et al. Major depression drives severity of American Urological Association Symptom Score. Urology. In press
18. Raison CL, Capuron L,Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24-31
19. Suzman R. The National Social Life, Health, and Aging Project: an introduction. J Gerontol B Psychol Sci Soc Sci 2009; 64 Suppl. 1: i5-11
20. Sbarra DA. Marriage protects men from clinically meaningful elevations in C-reactive protein: results from the National Social Life, Health, and Aging Project (NSHAP). Psychosom Med 2009; 71: 828-35
21. Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 2007; 61: 824-33
22. Allin KH, Nordestgaard BG, Zacho J, et al. C-reactive protein and the risk of cancer: a Mendelian randomization study. J Natl Cancer Inst 2010; 102: 202-6
23. Ford ME, Kelly PA. Conceptualizing and categorizing race and ethnicity in health services research. Health Serv Res 2005; 40: 1658-75
24. Fullilove MT. Deconstructing race in medical research. Arch Pediatr Adolesc Med 1994; 148: 1014-5
25. LaVeist TA. Beyond dummy variables and sample selection: what health services researchers ought to know about race as a variable. Health Serv Res 1994; 29: 1-16
26. McDade TW, Hawkley LC, Cacioppo JT. Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago Health, Aging, and Social Relations Study. Psychosom Med 2006; 68: 376-81
27. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, et al. Ethnic differences in C-reactive protein concentrations. Clin Chem 2008; 54: 1027-37
28. Goodwin JS, Hunt WC, Key CR, et al. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA 1987; 258: 3125-30
29. Johnson NJ, Backlund E, Sorlie PD, et al. Marital status and mortality: the National Longitudinal Mortality Study. Ann Epidemiol 2000; 10: 224-38
30. Johnson T, Master V. Separated and other unmarried patients experience higher rates of cancer-specific mortality: a SEER Database study. Cancer. In press
31. Sprehn GC, Chambers JE, Saykin AJ, et al. Decreased cancer survival in individuals separated at time of diagnosis: critical period for cancer pathophysiology? Cancer 2009; 115: 5108-16
32. Kiecolt-Glaser JK,McGuire L, Robles TF, et al. Psychoneuroimmunology and psychosomatic medicine: back to the future. Psychosom Med 2002; 64: 15-28
33. O'Reilly DS, Upton MN, Caslake MJ, et al. Plasma C reactive protein concentration indicates a direct relation between systemic inflammation and social deprivation. Heart 2006; 92: 533-5
34. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-207
35. EderK, Baffy N, Falus A, et al. Themajor inflammatory mediator interleukin-6 and obesity. Inflamm Res 2009; 58: 727-36
36. Wilson AM, Ryan MC, Boyle AJ. The novel role of C-reactive protein in cardiovascular disease: riskmarker or pathogen. Int J Cardiol 2006; 106: 291-7
37. McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009; 12: 223-6
38. Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010; 6: 149-63
39. Erlinger TP, Platz EA, Rifai N, et al. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004; 291: 585-90 (Pubitemid 38500312)